Disclosures The project was funded from the following sources:

Slides:

Advertisements

Similar presentations

Financial Conflict of Interest July 2012 rev

Advertisements

Managing Conflicts of Interest © ACCME.

Conflicts of Interest in Research: Policies and Regulations Marie Barron, M.A., COI Program Specialist Rick Lyons, M.D., Ph.D., COI Committee C Chair.

Sample Disclosure Slides Information: A presenter must include Disclosure slides for each presentation – even if nothing to disclose Two slides are required.

Japan Society for Hematopoietic Cell Transplantation COI disclosure Name of first author ： e.g., John Doe I have no personal or financial interests to.

Managing Conflicts of Interest © ACCME.

[Session Number: Title] [Speaker Optional: Job title Institution]

Financial Disclosures Financial interests, arrangements or affiliations that could be perceived as a real or apparent “conflict of interest” in the context.

COI Disclosure Information Example 2-1 Lead Presenter: Jane Doe Responsible Researcher: Jane Smith We have no financial relationships to disclose.

Financial Interest Disclosure (over the past 24 months) Commercial Interest Relationship Company A advisory board, consultant, investigator Company B speaker.

Kyle Conner, MA, CIP Associate Director, Office of Human Research

[Sample statement for poster presentations]

Kyle Conner, MA, CIP Associate Director, Office of Human Research

様式１AB （Ｆｏｒｍ　4－C）　Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.

Faculty Disclosure Off-Label Product Use

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

The Japanese Circulation Society COI Disclosure Name of Authors :

Relevant Financial Disclosure(s)

Conflict of Interest Disclosure <First Name> <Last Name>, <Degree>

Japanese Society of Allergology COI Disclosure Name of lead presenter

Conflict of Interest Disclosure Form

Disclosure information

Faculty Disclosure Off-Label Product Use

The Japanese Circulation Society COI Disclosure Name of Authors :

The Japanese Circulation Society COI Disclosure Name of Authors :

At the end of poster presentation, disclose COI status.

Has no real or apparent conflicts of interest to report.

<Title> <sub-title>

Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.

Conflict of Interest Disclosure (over the past 24 months)

Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.

Disclosure of conflicts of interest – explanation

If yes, give company names.

COI Disclosure All authors Name : （◎ Corresponding author）

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

DISCLOSURE INFORMATION

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

Financial Disclosure Financial Interest / Affiliation

Faculty Disclosure Off-Label Product Use

Form 1-A　　(There is a state of conflict of interest (in the past three years) requiring disclosure) The Japanese Society of Gastroenterology (JSGE) COI.

DISCLOSURE INFORMATION

Use the following slide to disclose any conflicts of interest

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

Conflict of Interest Disclosure Form

Disclosure of conflicts of interest

様式１AB （Ｆｏｒｍ　4－C）　Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.

COI Disclosure Name of Lead Presenter:○○○○

Disclosure of conflicts of interest

Conflict of Interest Disclosure Statement

Faculty Disclosure Off-Label Product Use

If yes, give names of authors and entities.

Faculty Disclosure Off-Label Product Use

If yes, give company names.

Conflict of Interest Disclosure , Salary: Royalty: Receipt of Intellectual Property Rights/Patent Holder: Consulting Fees.

COI Disclosure All authors Name : （◎ Corresponding author）

Japanese Society of Nephrology ＣＯＩ disclosure presenter： ○○○○,. ○○○○(

TITLE & AUTHORS Presenter Name, Institution, Country.

Financial and Other Disclosures

Financial Disclosure Financial Interest / Affiliation

TITLE Presenter Name Institution Country

Declaration of conflict of interest

< Title > < Sub-title >

Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.

Please include this slide if you answered “yes” to at least one of the questions.

The sample slide format is presented to disclose COI status, when there are no conflicts of interest. This should be used when giving a presentation at.

Conflict of Interest Disclosure <First Name> <Last Name>, <Degree>

Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.

Conflict of Interest Disclosure Form

COI Disclosure For speakers with a COI to declare

Presentation transcript:

Disclosures The project was funded from the following sources: Source A Source B ….. The following personal or financial relationships relevant to this presentation existed during the past 12 months/during the conduct of the study: Employment by commercial entity Consultancies or advisory Board memberships Lecture fees paid by a commercial entity (honoraria) Expert witness for a commercial entity Industry-sponsored grants (received or pending) including contracted research Patents received or pending Royalties from a commercial entity Stock ownership or options Other